Gene · 23643
Papers4,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants. | Int J Mol Sci | 2024 | 38791489 | PubTator, text mining | PubMed |
Lysophosphatidylcholine Acetyltransferase 2 (LPCAT2) Influences the Gene Expression of the Lipopolysaccharide Receptor Complex in Infected RAW264.7 Macrophages, Depending on the E. coli Lipopolysaccharide Serotype. | Biology (Basel) | 2024 | 38785798 | PubTator, text mining | PubMed |
| Assessment on malvidin-3-glucoside interaction with TLR4 via multi-spectroscopic analysis and molecular docking. | Spectrochim Acta A Mol Biomol Spectrosc | 2024 | 38761477 | PubTator, text mining | PubMed |
| Oxypeucedanin hydrate alleviates rheumatoid arthritis by inhibiting the TLR4-MD2/NF-κB/MAPK signaling axis. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38734936 | PubTator, text mining | PubMed |
| Lymphocyte antigen 96: A new potential biomarker and immune target in Parkinson's disease. | Exp Gerontol | 2024 | 38614225 | PubTator, text mining | PubMed |
| Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses. | Chemistry | 2024 | 38587187 | PubTator, text mining | PubMed |
| Gallic Acid-Modified Polyethylenimine-Polypropylene Carbonate-Polyethylenimine Nanoparticles: Synthesis, Characterization, and Anti-Periodontitis Evaluation. | ACS Omega | 2024 | 38559964 | PubTator, text mining | PubMed |
| Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation. | Phytomedicine | 2024 | 38518649 | PubTator, text mining | PubMed |
| Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma. | Heliyon | 2024 | 38515694 | PubTator, text mining | PubMed |
| SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants. | J Genet Eng Biotechnol | 2024 | 38494253 | PubTator, text mining | PubMed |
| Structured Tandem Repeats in Protein Interactions. | Int J Mol Sci | 2024 | 38474241 | PubTator, text mining | PubMed |
| The potential crosstalk genes and molecular mechanisms between glioblastoma and periodontitis. | Sci Rep | 2024 | 38472293 | PubTator, text mining | PubMed |
| A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma. | Transl Cancer Res | 2024 | 38410237 | PubTator, text mining | PubMed |
| Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents. | Pharmaceuticals (Basel) | 2024 | 38399416 | PubTator, text mining | PubMed |
| IRF3 function and immunological gaps in sepsis. | Front Immunol | 2024 | 38375470 | PubTator, text mining | PubMed |
| Characterization of a Myeloid Differentiation Factor 2-Derived Peptide that Facilitates THP-1 Macrophage-Mediated Phagocytosis of Gram-Negative Bacteria. | ACS Infect Dis | 2024 | 38363869 | PubTator, text mining | PubMed |
| Myeloid differentiation factor 2 inhibitors exert protective effects on lipopolysaccharides-treated human dental pulp cells via suppression of toll-like receptor 4-mediated signaling. | J Dent Sci | 2024 | 38303896 | PubTator, text mining | PubMed |
| Molecular recognition of Escherichia coli R1-type core lipooligosaccharide by DC-SIGN. | iScience | 2024 | 38299112 | PubTator, text mining | PubMed |
| Advances in endotoxin analysis. | Adv Clin Chem | 2024 | 38280803 | PubTator, text mining | PubMed |
| Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2024 | 38277535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23643/papers?page=11